
Clevidipine
CAS No. 167221-71-8
Clevidipine( Clevidipine | Clevidipine butyrate | Cleviprex | 167221-71-8 | Clevelox | Rac-Clevidipine )
Catalog No. M12548 CAS No. 167221-71-8
A dihydropyridine L-type calcium channel blocker, highly selective for vascular and has little or no effect on myocardial contractility or cardiac conduction.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 31 | In Stock |
![]() ![]() |
10MG | 43 | In Stock |
![]() ![]() |
25MG | 79 | In Stock |
![]() ![]() |
50MG | 122 | In Stock |
![]() ![]() |
100MG | 200 | In Stock |
![]() ![]() |
200MG | 360 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameClevidipine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA dihydropyridine L-type calcium channel blocker, highly selective for vascular and has little or no effect on myocardial contractility or cardiac conduction.
-
DescriptionA dihydropyridine L-type calcium channel blocker, highly selective for vascular and has little or no effect on myocardial contractility or cardiac conduction; reduces mean arterial blood pressure by decreasing systemic vascular resistance.Hypertension Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsClevidipine | Clevidipine butyrate | Cleviprex | 167221-71-8 | Clevelox | Rac-Clevidipine
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorAChR|CalciumChannel
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number167221-71-8
-
Formula Weight456.3164
-
Molecular FormulaC21H23Cl2NO6
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
-
Chemical Name3,5-Pyridinedicarboxylic acid,4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schwieler JH, et al. J Cardiovasc Pharmacol. 1999 Aug;34(2):268-74.
2. Ericsson H, et al. Eur J Pharm Sci. 1999 Apr;8(1):29-37.
3. Huraux C, et al. Anesth Analg. 1997 Nov;85(5):1000-4.
molnova catalog



related products
-
Vatanidipine
Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.
-
Felodipine
Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker.
-
Efonidipine hydrochl...
Efonidipine (NZ-105) is a potent, dual T-type and L-type calcium channel blocker.